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Abstract 
Background: Dogs are the main reservoir hosts of Leishmania infantum; nevertheless, recent investigations indicate 
a likely role for cats in the epidemiology of Leishmania infection. Feline leishmaniosis (FeL) remains poorly character-
ised, partly due to the lack of suitable diagnostic tools. This study aimed to compare serum amyloid A (SAA) levels and 
serum protein electrophoresis (SPE) profiles (specifically, alpha 2 and gamma globulins) in cats naturally exposed to or 
infected by L. infantum from southern Italy versus those of healthy controls and versus cats with neoplastic or inflam-
matory conditions from non-endemic areas.
Methods: Serum or plasma samples from four cohorts of cats were analysed for SAA levels and by SPE: (i) G1: 
healthy controls from Leishmania-non-endemic regions of Switzerland; (ii) G2: cats pre-diagnosed with neoplastic or 
inflammatory conditions available from the University of Cambridge sample archive; (iii) G3: L. infantum-seropositive, 
quantitative (q)PCR-negative cats from southern Italy; (iv) G4: L. infantum-seropositive and qPCR-positive cats from 
southern Italy. SAA data were assessed for normality and homoscedasticity using the Shapiro–Wilk and Levene’s tests, 
respectively; the Kruskall–Wallis test, followed by Dunn’s test with Bonferroni correction were subsequently used to 
compare SAA serum levels between groups. A weighted generalised linear model with a binomial distribution was 
used to assess statistically significant differences in the numbers of animals displaying elevated gamma globulins and 
increased alpha 2 globulins between groups.
Results: Overall, 68 samples were analysed (G1: n = 16, G2: n = 20, G3: n = 20, G4: n = 12). Cats suffering from neo-
plastic and inflammatory conditions (G2 ) showed significantly higher SAA levels than healthy controls (G1) (median 
values [interquartile range]: G1: 0.00 [0.00–0.00] mg/l versus G2: 0.85 [0.00–49.55] mg/l). G2, G3 and G4 cats showed 
higher percentages of individuals with increased alpha 2 globulins (percentages ± standard error: G1 = 20.0% ± 10.3, 
G2 = 80.0% ± 8.9, G3 = 70.0% ± 10.2, G4 = 75.0% ± 12.5) and gamma globulins (G1 = 0.0% ± 0, G2 = 65.0% ± 10.7, 
G3 = 50.0% ± 11.2, G4 = 58.3% ± 14.2) than healthy control cats (G1). For all three markers, no significant difference 
between cats within G2, G3 and G4 was recorded.
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Background
Zoonotic visceral leishmaniosis (ZVL) is a neglected 
disease caused by Leishmania infantum, transmitted by 
Phlebotomus spp. sand flies in the Old World [1]. The 
disease is distributed worldwide and endemic in many 
regions, including the Mediterranean basin [2]. Dogs are 
the main reservoir hosts of L. infantum [3]. Canine leish-
maniosis (CanL) is endemic in Italy, and the prevalence 
of infection has increased with its spread from hyper-
endemic southern and central areas towards northern 
regions [4]. The epidemiological role of other animal spe-
cies as alternative reservoir hosts of L. infantum has long 
been overlooked. Nevertheless, recent epidemiological 
investigations in other species have pointed towards the 
likely implication of  domestic and wild felids in parasite 
circulation [5–8]. In particular, endemic foci of feline 
leishmaniosis (FeL) have recently been described in 
southern Italy, and the overall prevalence of feline infec-
tion in these areas is likely underestimated [9, 10].
FeL is often subclinical [11–13], with clinical cases 
mainly characterised by cutaneous lesions, with crusty 
or nodular dermatitis being the most common presenta-
tion [14], whilst lymphadenomegaly seldom reported [5]. 
Typical diagnostic samples include skin (lesions), lymph 
node, bone marrow and blood [14, 15]. When present, 
clinical signs are non-specific, and alterations in hae-
matological, biochemical and urinary profiles, typically 
detected in dogs with leishmaniosis [16], may support 
suspicion of FeL. Due to the frequently subclinical nature 
of the infection, a straightforward measure of disease 
progression and response to treatment would facilitate 
the clinical management of FeL. The measurement of 
acute phase proteins (APPs), including C-reactive pro-
tein (CRP), haptoglobin and serum amyloid A (SAA), is 
increasingly being  applied to the diagnosis, monitoring 
and prognosis of a range of veterinary inflammatory con-
ditions [17, 18], including L. infantum infection in dogs 
[16, 19].
The acute phase response is an early, non-specific 
defence mechanism characterised by the release of pro-
inflammatory cytokines that stimulate an increase in 
serum APPs in response to infection, inflammation, tis-
sue injury, neoplasia and other processes [20]. In dogs 
naturally infected by L. infantum, a significant increase 
in the release of APPs, including CRP, haptoglobin and 
ceruloplasmin is observed, irrespective of the occurrence 
of clinical signs [19]. SAA is considered to be a less sensi-
tive indicator of CanL compared to other APPs [21]; nev-
ertheless, SAA is a major indicator of feline inflammatory 
conditions, including trauma, post-operative inflamma-
tion and sepsis [22–24]. SAA is substantially increased in 
cats with clinical signs of vector-borne infections, such 
as  those caused by Hepatozoon felis and Babesia vogeli, 
compared to uninfected and subclinically infected cats 
[25]. Recently, protein-related laboratory abnormalities 
were reported in tigers naturally infected by L. infan-
tum [26]. While information on serum APP levels in cats 
infected with vector-borne pathogens remains limited 
[25], these findings may suggest a useful diagnostic and 
prognostic role for SAA.
Serum protein electrophoresis (SPE) is a straightfor-
ward method to measure specific serum proteins and 
separate these into fractions. The alpha 2 fraction in 
SPE contains a number of APPs; thus its quantification 
may  be useful to diagnose inflammatory processes [27]. 
However, the levels of alpha 2 globulin in SPE in FeL have, 
thus far, not been investigated in detail. In one study, 
FeL-infected cats showed significantly lower levels of the 
alpha 2 globulin fraction compared to uninfected cats, 
with median alpha 2 globulin levels remaining within the 
reference range for infected cats [28]. In another study, 
FeL-positive cats did not show significantly higher alpha 
2 globulin levels compared to negative controls [29]. SPE 
is commonly used to identify and characterise gammopa-
thy in dogs infected by L. infantum [16, 30]. Gammopa-
thy normally occurs in both CanL and FeL [15, 28, 29].
In this scenario, the aim of the present study was to 
evaluate and compare the serum SAA levels and SPE pro-
files, specifically those of alpha 2 and gamma globulins, 
in cats from a ZVL-endemic area naturally exposed to or 
infected by L. infantum versus healthy cats and cats with 
pre-diagnosed neoplastic or inflammatory conditions.
Methods
Enrolment and diagnostic procedures
A total of 68 serum or plasma samples were obtained 
from four groups of cats:
Conclusions: This study indicates that the proportions of animals with elevated levels of alpha 2 and gamma globu-
lins are significantly higher in cats exposed to and infected with L. infantum. Levels of SAA and alpha 2 and gamma 
globulins may not be used to differentiate between L. infantum infection or exposure, and neoplastic and/or inflam-
matory conditions.
Keywords: Acute phase protein, Alpha 2 globulins, Feline leishmaniosis, Gamma globulins, Leishmania infantum, 
Phlebotomine sand flies, Serum amyloid A, Serum protein electrophoresis
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Group 1 (G1): 16 healthy control cats from Leishma-
nia-non-endemic regions of Switzerland (north of 
the Alps). The samples originated from the archives 
of the Clinical Laboratory or the Institute of Parasi-
tology, Vetsuisse Faculty, University of Zurich (Vet-
Lab Zurich and IPZ, respectively), and included 
healthy stray cats recruited into a spay/neuter pro-
gramme (n = 5), healthy blood donors (n = 6) and 
healthy laboratory cats (n = 5). All cats were recorded 
as clinically healthy following a thorough clinical 
examination by an accredited veterinary surgeon. 
Routine haematology and biochemistry analyses 
were performed with samples from blood donors, 
and animals that had travelled abroad were excluded. 
Cats from the spay and neuter programme were 
recruited only from the north of the Alps, a Leishma-
nia-free area. Laboratory animals are born and kept 
in controlled experimental units, with no exposure to 
Phlebotominae. The G1 group included 3 plasma and 
13 serum samples.
Group 2 (G2): 20 cats pre-diagnosed with neoplastic 
or inflammatory conditions selected from the sam-
ple archive of the Queen’s Veterinary School Hospi-
tal of the University of Cambridge. These cats origi-
nated from a Leishmania-free, namely the UK, and 
had not travelled abroad.
Group 3 (G3): 20 cats from southern Italy (i.e. Aeo-
lian Islands, Sicily and Apulia regions) testing sero-
positive for L. infantum by immune-fluorescence 
antibody test (IFAT), but negative by quantitative 
(real-time) PCR (qPCR).
Group 4 (G4): 12 cats from southern Italy (Aeolian 
Islands, Sicily) testing seropositive by IFAT and qPCR 
positive for L. infantum.
G3 and G4 samples were derived from previous pub-
lished studies on FeL conducted in southern Italy [10]. 
In particular, all cats included in the study by Otranto 
et  al. [10] were tested for co-infections with other vec-
tor-borne diseases (VBDs) (i.e. Anaplasma spp., Babesia 
spp., Ehrlichia spp., Hepatozoon spp. and Bartonella spp.) 
as well as with feline leukaemia and feline immunodefi-
ciency viruses (FeLV and FIV, respectively). Only samples 
from cats that tested positive for Leishmania, but nega-
tive for other VBDs and FIV and FeLV infections, were 
assessed in the present study.
Detection of antibodies against L. infantum was per-
formed by IFAT, as described by Otranto et al. [31], using 
a cut-off value of 1:80 [32]. Blood and conjunctival swabs 
from the enrolled cats were subjected to DNA extraction, 
using the DNeasy Blood & Tissue Extraction Kit (Qia-
gen, Hilden, Germany), according to the manufacturer’s 
instructions. The detection of a L. infantum kinetoplast 
DNA minicircle fragment (120  bp) was achieved by 
qPCR, using primers, probes and protocol described 
elsewhere [33].
SAA and serum protein electrophoresis
The SAA concentrations were determined using a tur-
bidimetric immunoassay kit (LZ-SAA; Eiken Chemical 
Co., Tokyo, Japan), with analysis on an automated ana-
lyser (Olympus AU480; Beckman Coulter Inc., Fullerton, 
USA). SPE was performed on alkaline buffered agarose 
gels using the Hydragel Protein(e) K20 electrophoresis 
system (SEBIA, Lisses, France), according to the manu-
facturer’s instructions, using 10-µl of each  serum sam-
ple. The gels were analysed with the Perfection V700 
Photo imaging densitometer (Seiko Epson Corp., Suwa, 
Nagano, Japan), using SEBIA Phoresis Rel 8.6.3 software 
(Magiras Diagnostics, Likovrisi, Greece). Total protein 
was measured using the biuret method on an automated 
analyser (Olympus AU480; Beckman Coulter Inc.). The 
numbers of cats whose plasma/sera displayed increased 
alpha 2 and gamma peaks on SPE were counted for each 
group according to reference intervals calculated by Tay-
lor and colleagues [27]. Clonality of increased gamma 
peaks was assessed, with monoclonal gammopathies (as 
opposed to polyclonal gammopathies) defined as show-
ing a narrow gamma peak, with a base width similar to 
the albumin peak or with peak height exceeding four-fold 
the peak width [27].
Statistical analyses
The values of SAA within each group were neither nor-
mally distributed (Shapiro–Wilk test, W = 0.47, P < 0.001) 
nor homoscedastic (Levene’s test, F3, 63 = 11.30, P < 0.001). 
Data transformation did not allow distribution normali-
sation nor variance homogenisation. Therefore, non-par-
ametric statistical tests were used. The Kruskall–Wallis 
test, followed by Dunn’s multiple comparison test with 
Bonferroni correction, was used to compare SAA serum 
levels between groups. Standard errors for the propor-
tions (SEp) were calculated as: SEp =
√
p(1− p)/n.
Differences in the numbers of cats displaying increased 
alpha 2 globulins and gamma globulins between groups 
were analysed by using a weighted generalised lin-
ear model (GLZ) with a binomial distribution to model 
increased alpha 2 globulins and gamma globulins out-
comes. For both parameters, a GLZ with a fixed factor 
was used: y = Xß + ε, where y is the vector of the obser-
vation (i.e. outcome: increased = 1, not increased = 0), X 
is the incidence matrix, ß is the vector of the fixed effect 
(i.e. the tested group) and ε is the vector of the random 
residual effects (P = 0.05).
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All statistical analyses were performed with JMP® 9 
(SAS Institute, Cary, NC, USA) with α = 0.05 as threshold 
to detect significant differences.
Results
Of 68 samples analysed, one G1 (healthy control) sam-
ple did not undergo SPE, while one G4 (positive for 
L. infantum by both IFAT and qPCR) sample did not 
undergo SAA analysis as insufficient sample was available 
(Table 1).
Median values and interquartile ranges of SAA con-
centration in pathological groups were as follows: 
G2 = 0.85 (0.0–49.55) mg/l, G3 = 0.0 (0.0–4.53) mg/l and 
G4 = 0.0 (0.0–7.5) mg/l); in G1, values of 0.00 (0.0–0.00) 
mg/l were recorded. SAA concentrations differed signifi-
cantly among tested groups (χ2 = 13.56, df = 3, P = 0.004). 
In particular, this marker was significantly higher in 
G2 when compared to G1  controls (Z = 3.62, df = 1, 
P = 0.002), while no significant differences were detected 
between G3 or G4 versus G1. No differences in SAA con-
centration were detected among G2, G3 and G4 (Fig. 1).
The proportion of cats showing increased alpha 2 and 
gamma globulins on SPE differed significantly among 
experimental groups (χ2 = 15.56, df = 3, P = 0.0014 and 
χ2 = 22.225, df = 3, P < 0.0001, respectively) (Fig.  1). In 
particular, the proportion of cats showing increased 
alpha 2 globulins on SPE was significantly higher in cats 
from G2, G3 and G4 (percentage ± SE: G2 = 80.0% ± 8.9, 
G3 = 70.0% ± 10.2, G4 = 75.0% ± 12.5) compared to 
healthy controls (G1 = 20.0% ± 10.3 and 0% ± 0) (G1 
versus G2: χ2 = 13.23, df = 1, P = 0.0003; G1 versus G3: 
χ2 = 9.05, df = 1, P = 0.003; G1 versus G4: χ2 = 8.59, 
df = 1, P = 0.003). A comparable trend was observed in 
the proportion of cats showing increased gamma globu-
lins on SPE, which was significantly higher in cats from 
G2, G3 and G4 (G2 = 65.0% ± 10.7, G3 = 50.0% ± 11.2, 
G4 = 58.3% ± 14.2) compared to healthy controls 
(G1 = 0% ± 0) (G1 versus G2: χ2 = 20.28, df = 1, P < 0.0001; 
G1 versus G3: χ2 = 14.15, df = 1, P = 0.0002; G1 versus G4: 
χ2 = 14.60, df = 1, P = 0.0001). No significant difference in 
the proportion of animals displaying increased alpha 2 
globulins or increased gamma globulins between G2, G3 
and G4 was observed  (Fig. 1). In all cases, gammopathy 
was polyclonal (not shown).
Discussion
In this study, SAA concentration was significantly higher 
in cats with neoplastic or inflammatory conditions (G2) 
than in healthy controls (G1), whereas no significant dif-
ferences in SAA concentrations were noted between 
Leishmania-infected (G3) or -exposed (G4) cats com-
pared to  healthy animals. Previous studies had shown 
that elevated SAA levels are associated with clinically 
overt cases of feline H. felis and B. vogeli infection [25]. In 
contrast, our data suggests that SAA concentration is not 
reliably linked to FeL.
The percentages of animals showing elevated alpha 
2 globulins were significantly higher in infected and 
exposed cats (G3 and G4) compared to healthy controls 
(G1), suggesting that the elevation of these markers, indi-
cating an acute phase response, is a significant feature 
of FeL. However, elevated alpha 2 globulins were also 
observed in cats with neoplastic and inflammatory condi-
tions compared with healthy controls, and therefore may 
not be considered robust indicators of FeL. Nevertheless, 
increased alpha 2 globulins are a recognised feature of 
infection in dogs [16], whereas previous studies on FeL 
have revealed either no significant difference in alpha 2 
globulin levels between infected and uninfected cats [29], 
or significantly lower alpha 2 globulins in FeL-infected 
cats [28]. In both above-mentioned studies [28, 29], the 
median alpha 2 globulin levels for infected cats remained 
within the reference range. However, the methodology 
implemented in our study differed in that we compared 
Table 1 Number of sampled cats, and serum protein electrophoresis and serum amyloid A results
qPCR Quantitative (real-time) PCR, SAA serum amyloid A, SPE serum protein electrophoresis
Reference ranges: SAA (mg/l): < 0.5; alpha 2 globulins (g/l) [27]: 2.94–10.25; gamma globulins (g/l) [27]): 4.33–21.40
a Data presented as median (interquartile range)













Total number of samples analysed 16 (15 for SPE) 20 20 12 (11 for SAA)
SAA results (mg/l)a 0.00 (0.00–0.00) 0.85 (0.00–49.55) 0.00 (0.00–4.53) 0.00 (0.00–7.5)
SPE  resultsb
 Alpha 2 globulins increased 3 (20.0 ± 10.3) 16 (80.0 ± 8.9) 14 (70.0 ± 10.2) 9 (75.0 ± 12.5)
 Gamma globulins increased 0 (0 ± 0) 13 (65.0 ± 10.7) 10 (50.0 ± 11.2) 7 (58.3 ± 14.2)
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the proportion of cats with elevated alpha 2 globulins, 
rather than the median alpha 2 globulin values between 
groups, thus aiming to answer the question of whether 
elevation of alpha 2 globulin values above the reference 
range is more common among FeL-infected cats com-
pared to non-infected cats.
The results suggest that elevated gamma globulins 
are a significant feature of Leishmania infection in cats, 
although (as reported for alpha 2 globulins) no signifi-
cant differences in gamma globulin concentrations were 
detected  between Leishmania-infected or -exposed cats 
and cats with other neoplastic or inflammatory condi-
tions. Hyperglobulinaemia has been recorded in most 
clinical cases of FeL [5, 14, 15]. In our study, all cases of 
gammopathy were polyclonal, in agreement with pub-
lished typical laboratory abnormalities associated with 
CanL [16] and the diagnostic recommendations for FeL 
[29].
There was no significant difference in SAA serum 
concentration, or in the percentage of animals show-
ing elevated gamma or alpha 2 globulins, between either 
group of animals infected by or exposed to L. infan-
tum (G3 and G4) and animals affected by neoplastic or 
inflammatory conditions (G2). This result  suggests that 
gamma and alpha 2 globulins are not specific markers of 
FeL; however, this does not preclude their role as part of 
a diagnostic plan and in monitoring and assessing dis-
ease  prognosis . The absence of a significant difference 
in gamma and alpha 2 globulins between these groups 
of cats suggests that these markers may be an important 
feature of both active infection and parasite exposure. It 
is also possible that G3 cats had a very low parasitaemia 
that went undetected by qPCR [cf. 34].
Fig. 1 Serum amyloid A (SAA) concentrations (a), and proportions of cats showing increased alpha 2 globulins (b) and increased gamma 
globulins (c) on serum protein electrophoresis (SPE), in healthy control cats (G1: n = 16; 15 serum samples for SPE), cats affected by neoplastic or 
inflammatory conditions  (N/I) (G2: n = 20), cats seropositive and qPCR-negative for Leishmania infantum (L+/-) (G3: n = 20) and cats seropositive and 
qPCR-positive for L. infantum (L+/+) (G4: n = 12; 11 serum samples for SAA). a Red boxplots indicate the median (solid line) within each box and the 
range of dispersion (lower and upper quartiles and outliers); means and standard errors are represented by green lines and blue T-bars, respectively; 
the letters above boxplots indicate significant differences among groups (Dunn’s test with Bonferroni correction, P < 0.05). b, c letters above 
columns indicate significant differences among groups (generalised linear model, binomial distribution, P < 0.05)
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A limitation of our study is that the ‘healthy control’ 
animals (G1) and the neoplastic and inflammatory dis-
ease group (G2) were not tested to rule out L. infan-
tum infection. However, these cats were from ZVL-free 
areas of Switzerland (G1) and the UK (G2), respec-
tively, and included laboratory animals bred and kept 
in a controlled environment as well as blood donor cats. 
Furthermore, G3 and G4 animals were not tested for 
concurrent inflammatory disease, such as feline infec-
tious peritonitis, sepsis or gingivitis, all of which would 
induce an acute phase response and elevated gamma 
globulins.
In conclusion, the results of this study suggest that 
elevated alpha 2 and gamma globulins in cats may not be 
used to differentiate between infection and/or exposure 
to L. infantum and the occurrence of other inflammatory 
conditions.
Abbreviations
APP: Acute phase protein; CRP: C-reactive protein; ELISA: Enzyme-linked 
immunosorbent assay; FeL: Feline leishmaniosis; IFAT: Immunofluorescence 
antibody test; qPCR: Quantitative (real-time) PCR; SAA: Serum amyloid A; SPE: 
Serum protein electrophoresis; ZVL: Zoonotic visceral leishmaniosis.
Acknowledgements
Many thanks to Miranda Garfoot (Queen’s Veterinary School Hospital, Uni-
versity of Cambridge) for technical help with the laboratory methods (SPE 
and SAA measurement) and Eva-Maria Zottler for participating in sample 
collections.
Authors’ contributions
GS carried out SPE and SAA measurements. GS and GB analysed and inter-
preted the data. GS was the main contributor in writing the manuscript, with 
advice and guidance from CC, GB, DO and RI. JA, MS and EB provided the 
samples together with advice and information. GS, JA, EB and DO contributed 
to study design, with guidance from all other authors. All authors read and 
approved the final manuscript.
Funding
The study was a veterinary final year elective project funded internally by the 
University of Cambridge Department of Veterinary Medicine.
Availability of data and materials
The datasets used and analysed during the current study are available from 
the corresponding author on reasonable request.
Declarations
Ethics approval and consent to participate
All procedures described in this work comply with the ethical standards of 
the relevant national and institutional guides. All samples used were surplus 
diagnostic samples and were not specifically collected for this study. For 
healthy control cats from Switzerland, the objective and design of the study 
were approved for owned, shelter and stray cats by the owners, shelter 
administrator and animal welfare organisers of the neutering campaigns, 
respectively. Written consent was obtained from all owners of patients at 
the Queen’s Veterinary School Hospital of the University of Cambridge, 
permitting surplus diagnostic samples to be used for research. All samples are 
archived according to the Department of Veterinary Medicine animal welfare 
guidelines. Cats from ZVL-endemic areas were sampled under the framework 
of a field study approved by the Italian Ministry of Health (authorisation no. 
0006088–10/03/2015-DGSAF-COD_UO-P), and the cats’ owners provided 




The authors declare that they have no competing interests.
Author details
1 Department of Veterinary Medicine, University of Cambridge, Cambridge, 
UK. 2 Dipartimento di Scienze Veterinarie, Università degli Studi di Messina, 
Messina, Italy. 3 Department of Agriculture, Food and Environment, University 
of Pisa, Pisa, Italy. 4 Institute of Parasitology, Vetsuisse Faculty, University 
of Zurich, Zurich, Switzerland. 5 Dipartimento di Medicina Veterinaria, Univer-
sità degli Studi di Bari Aldo Moro, Bari, Italy. 
Received: 19 January 2021   Accepted: 31 March 2021
References
 1. Maroli M, Feliciangeli MD, Bichaud L, Charrel RN, Gradoni L. Phlebotomine 
sandflies and the spreading of leishmaniases and other diseases of public 
health concern. Med Vet Entomol. 2013;27:123–47.
 2. WHO (World Health Organisation). Leishmaniasis. https:// www. who. int/ 
leish mania sis. Accessed 23 Aug 2020.
 3. Baneth G, Koutinas AF, Solano-Gallego L, Bourdeau P, Ferrer L. Canine 
leishmaniasis—new concepts and insights on an expanding zoonosis: 
part one. Trends Parasitol. 2008;24:324–30.
 4. Mendoza-Roldan J, Benelli G, Panarese R, Iatta R, Furlanello T, Beugnet 
F, et al. Leishmania infantum and Dirofilaria immitis infections in Italy, 
2009–2019: changing distribution patterns. Parasit Vectors. 2020;13:193.
 5. Pennisi MG, Cardoso L, Baneth G, Bourdeau P, Koutinas A, Miró G, et al. 
LeishVet update and recommendations on feline leishmaniosis. Parasit 
Vectors. 2015;8:302.
 6. Soares CS, Duarte SC, Sousa SR. What do we know about feline leishma-
niasis? J Feline Med Surg. 2016;18:435–42.
 7. Iatta R, Furlanello T, Colella V, Tarallo VD, Latrofa MS, Brianti E, et al. A 
nationwide survey of Leishmania infantum infection in cats and associ-
ated risk factors in Italy. PLoS Negl Trop Dis. 2019;13:e0007594.
 8. Iatta R, Zatelli A, Laricchiuta P, Legrottaglie M, Modry D, Dantas-Torres F, 
et al. Leishmania infantum in tigers and sand flies from a leishmaniasis-
endemic area, southern Italy. Emerg Infect Dis. 2020;26:1311–4.
 9. Pennisi MG, Lupo T, Malara D, Masucci M, Migliazzo A, Lombardo G. 
Serological and molecular prevalence of Leishmania infantum infection in 
cats from Southern Italy. J Feline Med Surg. 2012;14:656–7.
 10. Otranto D, Napoli E, Latrofa MS, Annoscia G, Tarallo VD, Greco G, et al. 
Feline and canine leishmaniasis and other vector-borne diseases in the 
Aeolian Islands: pathogen and vector circulation in a confined environ-
ment. Vet Parasitol. 2017;236:144–51.
 11. Solano-Gallego L, Rodriguez-Cortes A, Iniesta L, Quintana J, Pastor J, 
Espada Y, et al. Cross-sectional serosurvey of feline leishmaniasis in ecore-
gions around the Northwestern Mediterranean. Am J Trop Med Hyg. 
2007;76:676–80.
 12. Maia C, Gomes J, Cristovão J, Nunes M, Martins A, Rebelo E, et al. Feline 
Leishmania infection in a canine leishmaniasis endemic region, Portugal. 
Vet Parasitol. 2010;174:336–40.
 13. Nasereddin A, Salant H, Abdeen Z. Feline leishmaniasis in Jerusalem: 
serological investigation. Vet Parasitol. 2008;158:364–9.
 14. Fernandez-Gallego A, Bernabe LF, Dalmau A, Esteban-Saltiveri D, Font A, 
Leiva M, et al. Feline leishmaniosis: diagnosis, treatment and outcome in 
16 cats. J Feline Med Surg. 2020;22:993–1007.
 15. Pennisi MG, Hartmann K, Lloret A, Addie D, Belák S, Boucraut-Baralon C, 
et al. Leishmaniasis in cats ABCD guidelines on prevention and manage-
ment. J Feline Med Surg. 2013;15:638–42.
 16. Paltrinieri S, Gradoni L, Roura X, Zatelli A, Zini E. Laboratory tests for 
diagnosing and monitoring canine leishmaniasis. Vet Clin Pathol. 
2016;45:552–78.
 17. Martínez-Subiela S, Tecles F, Parra MD, Ceron JJ. Acute phase proteins: 
general concepts and main clinical applications in veterinary medicine. 
An Vet (Murcia). 2001;17:99–116.
Page 7 of 7Savioli et al. Parasites Vectors          (2021) 14:217  
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 18. Eckersall PD, Bell R. Acute phase proteins: biomarkers of infection and 
inflammation in veterinary medicine. Vet J. 2010;185:23–7.
 19. Martínez-Subiela S, Tecles F, Eckersall PD, Ceron JJ. Serum concentra-
tions of acute phase proteins in dogs with leishmaniasis. Vet Rec. 
2002;150:241–4.
 20. Cerón JJ, Eckersall PD, Martínez-Subiela S. Acute phase proteins in dogs 
and cats: current knowledge and future perspectives. Vet Clin Pathol. 
2005;34:85–99.
 21. Martínez-Subiela S, Ceron JJ. Serum amyloid A levels in canine leishma-
niasis. Vet Clin Pathol. 2002;31:205.
 22. Kajikawa T, Furuta A, Onishi T, Tajima T, Sugii S. Changes in concentrations 
of serum amyloid A protein, alpha-1-acid glycoprotein, haptoglobin, 
and C-reactive protein in feline sera due to induced inflammation and 
surgery. Vet Immunol Immunopathol. 1999;68:91–8.
 23. Sasaki K, Ma Z, Khatlani T, Okuda M, Inokuma H, Onishi T. Evaluation of 
feline serum amyloid A (SAA) as an inflammatory marker. J Vet Med Sci. 
2003;65:545–8.
 24. Tamamoto T, Ohno K, Ohmi A, Goto-Koshino Y, Tsujimoto H. Verification 
of measurement of the feline serum amyloid A (SAA) concentration by 
human SAA turbidimetric immunoassay and its clinical application. J Vet 
Med Sci. 2008;70:1247–52.
 25. Vilhena H, Tvarijonaviciute A, Cerón JJ, Vieira L, Pastor J, Silvestre-Ferreira 
AC. Acute phase proteins response in cats naturally infected with Hepato-
zoon felis and Babesia vogeli. Vet Clin Pathol. 2017;46:72–6.
 26. Cavalera MA, Iatta R, Laricchiuta P, Passantino G, Abramo F, Mendoza-
Roldan JA, et al. Clinical, haematological and biochemical findings in 
tigers infected by Leishmania infantum. BMC Vet Res. 2020;16:214.
 27. Taylor SS, Tappin SW, Dodkin SJ, Papasouliotis K, Casamian-Sorrosal D, 
Tasker S. Serum protein electrophoresis in 155 cats. J Feline Med Surg. 
2010;12:643.
 28. Spada E, Perego R, Vitale F, Bruno F, Castelli G, Tarantola G, et al. Feline 
Leishmania spp. infection in a non-endemic area of Northern Italy. Ani-
mals. 2020;10:817.
 29. Urbani L, Tirolo A, Salvatore D, Tumbarello M, Segatore S, Battilani M, et al. 
Serological, molecular and clinicopathological findings associated with 
Leishmania infantum infection in cats in Northern Italy. J Feline Med Surg. 
2020;22:935–43.
 30. Maia C, Campino L. Biomarkers associated with Leishmania infantum 
exposure, infection, and disease in dogs. Front Cell Infect Microbiol. 
2018;8:302.
 31. Otranto D, Paradies P, De Capraris D, Stanneck D, Testini G, Grimm F, et al. 
Toward diagnosing Leishmania infantum infection in asymptomatic 
dogs in an area where leishmaniasis is endemic. Clin Vaccine Immunol. 
2009;16:337–43.
 32. Iatta R, Trerotoli P, Lucchese L, Natale A, Buonavoglia C, Nachum-Biala 
Y, et al. Validation of a new immunofluorescence antibody test for 
the detection of Leishmania infantum infection in cats. Parasitol Res. 
2020;119:1381–6.
 33. Francino O, Altet L, Sanchez-Robert E, Rodriguez A, Solano-Gallego L, 
Alberola J, et al. Advantages of real-time PCR assay for diagnosis and 
monitoring of canine leishmaniosis. Vet Parasitol. 2006;137:214–21.
 34. Gradoni L, Gramiccia M. Leishmaniasis in OIE manual of standards for 
diagnostic tests and vaccine. 4th ed. Paris: Office International des Epizo-
oties; 2008. p. 803–12.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
